Apr 6, 2018

Verdensalt.dk | Archives | ~ United States Department of Justice ~ | Tuesday, September 5, 2017 - April 6, 2018 | **FOR IMMEDIATE RELEASE** | .. Novo Nordisk Agrees to Pay $58 Million for Failure to Comply with FDA-Mandated Risk Program.. | Blogger: [Wild revaluation: Novo's value is 2,300,000,000,000 DKK - TV 2 NEWS & CIT Bank] ... ⚕️ Holding Big Pharma accountable!!. That's a joke, right!! 💨 Sometimes pharma companies bend the rules. And increasingly, they're getting caught. How do they solve it? By settlement with the U.S. Attorney's office. A slap on the wrist and Novo Nordisk gets the ""NOD"" from U.S. drug purchaser for new diabetes hope Ozempic diabetes drug and many other evil drugs 💥 Novo Nordisk increased reported operating profit by 8% in the first six months of 2017 and 5% growth in total (DKK 49 billion) 💥 Reported sales were broadly unchanged at DKK 112 billion  Sales of Tresiba® increased by 155% to DKK 3.7 billion (149% in local currencies)  Sales of Victoza® increased by 21% to DKK 11.5 billion (18% in local currencies)  Sales of Saxenda® increased by 98% to DKK 1.2 billion (90% in local currencies)  Sales in North America Operations increased by 5% (2% in local currencies)  Sales in International Operations increased by 4% (5% in local currencies).. In short, Novo Nordisk U.S. Holdings Inc., which is a subsidiary of Novo Nordisk A/S of Denmark, the world's largest producer of insulin, trying to sell Victoza in America, ignoring high risk factors and symptoms, linked to ""dangerous side effects"", including pancreatitis and thyroid cancer 💣 BLACK BOX WARNINGS: Risk of thyroid C-cell tumors 💣In detail, the injectable Type 2 diabetes drug Victoza works by stimulating insulin production. It belongs to a class of drugs called GLP-1 mimetics. Studies link Victoza to pancreatitis, thyroid cancer and pancreatic cancer... Insulin maker Novo Nordisk said its Ozempic diabetes drug had been included on a list of medicines approved for patients covered by U.S. private health schemes, setting the stage for a battle with Eli Lilly's Trulicity... Bernie Sanders blasts Novo Nordisk for price hikes. Sanders contested Novo in the 2016 video, that the prices of some insulins had risen by 450 percent more than inflation over the past 20 years. President Trump stroves into the Oval office and threatened to use the hammer against the high drug prices and accusing and saying, that drugmakers, “are getting away with murder”. (Unfortunately, lobbyists have been convinced that they are Trumpeting Trump by the money monster - Trump's abandoned promise to bring down drug prices but combatting the opioid crisis??). In other words, it's ALWAYS people under the poverty line in the United States who dies, simply because they can not AFFORD Novo's diabetes medicine .... However, the company Novo, is acting like Teflon coating, that provides a very smooth surface and nothing sticks (Novo don't give a rats ass) ... It's about Petrodollars, Bribery and Power in the American system subject to the genetically-engineered political Washington D.C. and the almighty pharmaceutical industry ... |


READ MORE: https://www.justice.gov/opa/pr/novo-nordisk-agrees-pay-58-million-failure-comply-fda-mandated-risk-program
http://www.business.dk/medico/novo-nordisk-indgaar-forlig-paa-366-millioner-kroner
https://www.novonordisk.com/bin/getPDF.2126247.pdf
https://www.novonordisk.com/bin/getPDF.2165236.pdf
https://www.reuters.com/article/us-novo-nordisk-usa/novo-nordisk-gets-nod-from-u-s-drug-purchaser-for-new-diabetes-hope-idUSKCN1G527C

VIEW LAWSUIT INFORMATION-->   HTTPS://WWW.DRUGWATCH.COM/VICTOZA/